Puri Mail

Large Volume Parenteral Market Overview

According to Mordor Intelligence, the large volume parenteral market size is projected to grow from USD 9.32 billion in 2026 to USD 11.69 billion by 2031, registering a CAGR of 4.62% during the forecast period. The large volume parenteral market continues to experience stable growth as healthcare systems increasingly rely on intravenous therapies for patient treatment and recovery. large volume parenterals play a critical role in fluid replacement, nutritional support, drug delivery, and therapeutic care across hospitals, ambulatory facilities, and home-care settings. Their importance has grown alongside the increasing prevalence of chronic diseases, rising surgical procedures, and expanding healthcare access across both developed and emerging economies.

Healthcare providers are placing greater emphasis on efficient infusion therapy management, patient safety, and uninterrupted access to essential intravenous solutions. This trend is supporting steady demand across multiple treatment categories. In addition, healthcare organizations are investing in modern manufacturing technologies and supply chain infrastructure to ensure reliable product availability.

Large Volume Parenteral Market Trends

Growing Adoption of Home-Based Infusion Therapy

One of the leading Large Volume Parenteral market trends is the increasing use of home-care and alternate-site infusion services. Patients requiring long-term intravenous treatment are increasingly receiving care outside traditional hospital settings. This shift is supporting demand for convenient, safe, and easy-to-administer large volume parenteral products.

Expansion of Advanced Manufacturing Technologies

Manufacturers are increasingly adopting advanced production technologies to improve efficiency and product quality. Automated aseptic processing systems and modern fill-finish technologies are helping improve manufacturing consistency while supporting regulatory compliance. These investments are strengthening production capabilities across the Large Volume Parenteral industry.

Rising Demand for Nutritional and Therapeutic Infusions

The growing use of parenteral nutrition and therapeutic infusion treatments is contributing to market expansion. Healthcare providers are utilizing large volume parenterals to support patients with chronic illnesses, post-surgical recovery needs, and specialized nutritional requirements. This trend continues to support Large Volume Parenteral market growth across healthcare settings.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/large-volume-parenteral-market?utm_source=abnewswire

Large Volume Parenteral Market Segmentation

By Volume

• 100 – 250 mL

• 250 – 500 mL

• 500 – 1,000 mL

• 1,000 – 2,000 mL

• Above 2,000 mL

By Application

• Therapeutic Injections

• Fluid-Balance Injections

• Nutritious/Parenteral-Nutrition Injections

By Type of Packaging

• Glass Bottles

• Flexible Bags (PVC and Non-PVC)

By Manufacturing Technology

• Traditional Aseptic Fill-Finish

• Blow-Fill-Seal (BFS)

By End User

• Hospitals

• Home-Care and Alternate-Site Infusion

• Ambulatory Surgical Centers

By Geography

• North America

• Europe

• Asia-Pacific

• Middle East and Africa

• South America

Competitive Landscape of the Large Volume Parenteral Industry

The large volume parenteral industry remains competitive, with leading companies focusing on production capacity expansion, manufacturing efficiency, and supply chain resilience. Market participants are investing in advanced packaging technologies, aseptic production systems, and quality control processes to meet growing demand from healthcare providers.

Key Players

• Pfizer, Inc.

• B. Braun SE

• Otsuka Pharmaceutical Co.

• Fresenius Kabi AG

• Baxter International Inc.

Conclusion

The large volume parenteral market is expected to maintain steady growth as healthcare providers continue to expand the use of infusion therapies for patient care. Rising chronic disease prevalence, increasing surgical procedures, and growing demand for nutritional support therapies are expected to remain key market drivers.

Several large volume parenteral market trends, including home-based infusion programs, advanced manufacturing technologies, and flexible packaging adoption, are likely to support future market expansion. These developments are helping improve product availability and operational efficiency across healthcare systems.

The large volume parenteral market size is also expected to benefit from continued investments in healthcare infrastructure and pharmaceutical manufacturing capacity. Demand from hospitals, ambulatory surgical centers, and home-care providers is expected to create new opportunities throughout the forecast period.

Industry Related Reports

Hedgehog Pathway Inhibitors Market:

The hedgehog pathway inhibitors market is growing due to increasing incidence of cancers such as basal cell carcinoma and acute myeloid leukemia, rising adoption of targeted therapies, and ongoing advancements in oncology drug development. Expanding clinical research and personalized medicine approaches are further supporting market growth.

Get more insights: https://www.mordorintelligence.com/industry-reports/hedgehog-pathway-inhibitors-market?utm_source=abnewswire

Digital Therapeutics Market Size:

The digital therapeutics market is projected to grow from USD 9.98 billion in 2025 to USD 38.54 billion by 2031, registering a CAGR of 25.24% during 2026–2031. Growth is driven by increasing adoption of digital health solutions, rising prevalence of chronic diseases, and growing demand for personalized and remote patient care technologies.

Get more insights: https://www.mordorintelligence.com/industry-reports/digital-therapeutics-market?utm_source=abnewswire

Pericardiocentesis Procedures Market Share:

The pericardiocentesis procedures market was valued at USD 1.09 billion in 2025 and is projected to reach USD 1.50 billion by 2031, registering a CAGR of 5.63% during 2026–2031. Growth is driven by the increasing prevalence of cardiovascular disorders, rising incidence of pericardial effusion, and growing adoption of minimally invasive cardiac procedures.

Get more insights: https://www.mordorintelligence.com/industry-reports/pericardiocentesis-procedures-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected]

https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/